UBS Group AG - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$12,000
+9.1%
10,143
+78.6%
0.00%
Q1 2022$11,000
-38.9%
5,679
-54.2%
0.00%
Q4 2021$18,000
+50.0%
12,393
+181.7%
0.00%
Q3 2021$12,000
-69.2%
4,400
-55.1%
0.00%
Q2 2021$39,000
-59.4%
9,801
-51.2%
0.00%
Q1 2021$96,000
-17.2%
20,069
+22.2%
0.00%
Q4 2020$116,000
-50.8%
16,420
-26.6%
0.00%
Q3 2020$236,000
+293.3%
22,362
+231.9%
0.00%
Q2 2020$60,000
+1400.0%
6,737
+562.4%
0.00%
Q1 2020$4,000
-33.3%
1,017
-35.4%
0.00%
Q4 2019$6,000
-81.8%
1,574
-82.1%
0.00%
Q3 2019$33,0008,8100.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 732,135$1,940,0000.83%
Green Alpha Advisors, LLC 61,759$164,0000.11%
Values First Advisors, Inc. 49,179$130,0000.08%
GSA CAPITAL PARTNERS LLP 257,684$683,0000.07%
SHELTON CAPITAL MANAGEMENT 240,000$636,0000.02%
Walleye Capital LLC 154,997$411,0000.01%
PDT Partners, LLC 59,400$157,0000.01%
Archford Capital Strategies, LLC 13,091$35,0000.01%
Susquehanna International Group Ltd. 13,164$35,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$444,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders